Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

Dr. Georges Haas - biography

Dr. Georges Haas has a highly successful record of R&D management throughout his career with the Ciba-Geigy Group over the last 27 years. In his final position, he headed their Pharma Research and Preclinical Development worldwide with 2,200 employees in various locations in Europe, Japan and the United States. Dr Haas received a doctorate in chemistry from the ETH (Zürich) and international senior management training at Harvard. In addition to being the author of a number of publications, he holds many patents in the field of pharmaceuticals.

< back